Pivotal single arm study for CGM
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Pediatrics
330
Study Length: approximately 90 days
Target Age/Sex: ages 2 - 17, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures